Atlas Trials

A Study Of PF-03463275 As Add-On Therapy In Outpatients With Persistent Negative Symptoms Of Schizophrenia

Clinical trial NCT00977522 · TERMINATED

Trial details

NCT number
NCT00977522
Sponsor
Pfizer
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Schizophrenia
Start date
2009-11-01
Primary completion
2010-09-01
Enrollment
207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.